81 participants
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-06-20
- Start Date:
- 2013-08-28
- Completion:
- 2014-09-16
Conditions
- Parkinson Disease
Interventions
- DRUG